Biomarkers Predict p53 Gene Therapy Efficacy in Recurrent, Squamous Cell Carcinoma of the Head and Neck

被引：0

作者：

Nemunaitis, John ^{[1
]}

Clayman, Gary ^{[2
]}

Agarwala, Sanjiv ^{[3
]}

Hrushesky, William ^{[4
]}

Wells, James R. ^{[4
]}

Moore, Charles ^{[5
]}

Hamm, John ^{[6
]}

Yoo, George ^{[7
]}

Baselga, Jose ^{[8
]}

Murphy, Barbara A. ^{[9
]}

Menander, Kerstin A. ^{[10
]}

Licato, Laura L. ^{[10
]}

Chada, Sunil ^{[10
]}

Gibbons, Robert D. ^{[11
]}

Olivier, Magali ^{[12
]}

Hainaut, Pierre ^{[12
]}

Goodwin, W. Jarrard ^{[13
]}

Roth, Jack A. ^{[2
]}

Sobol, Robert E. ^{[10
]}

机构：

[1] Mary Crowley Canc Res Ctr, Dallas, TX USA

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] Univ Pittsburgh, Ctr Canc, Pittsburgh, PA USA

[4] WJB Dorn VA Med Ctr, Columbia, SC USA

[5] Emory Univ, Sch Med, Atlanta, GA 30322 USA

[6] Univ Louisville, Louisville, KY 40292 USA

[7] Wayne State Univ, Detroit, MI USA

[8] Hosp Gen Univ Vall Hebron, Barcelona, Spain

[9] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[10] Introgen Therapeut, Houston, TX USA

[11] Univ Illinois, Chicago, IL USA

[12] Int Agcy Res Canc, F-69372 Lyon, France

[13] Univ Miami, Sylvester Canc Ctr, Miami, FL USA

来源：

MOLECULAR THERAPY | 2009年 / 17卷

关键词：

D O I：

暂无

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

357

引用

页码：S139 / S139

页数：1

共 50 条

[31] Analysis of p53 antibody response in patients with squamous cell carcinoma of the head and neck
Lavieille, JP
Lubin, R
Soussi, T
Reyt, E
Brambilla, C
Riva, C
ANTICANCER RESEARCH, 1996, 16 (4C) : 2385 - 2388
[32] GENOTYPIC AND PHENOTYPIC ALTERATIONS OF P53 IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA
LAI, SL
BATSAKIS, JG
ORDONEZ, NG
LUNA, MA
GOEPFERT, H
ELNAGGAR, AK
ONCOLOGY REPORTS, 1995, 2 (06) : 1115 - 1120
[33] Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments
de Bakker, Tycho
Journe, Fabrice
Descamps, Geraldine
Saussez, Sven
Dragan, Tatiana
Ghanem, Ghanem
Krayem, Mohammad
Van Gestel, Dirk
FRONTIERS IN ONCOLOGY, 2022, 11
[34] p53 expression in concurrent chemoradiotherapy with docetaxel for head and neck squamous cell carcinoma
Oridate, Nobuhiko
Homma, Akihiro
Higuchi, Eisaku
Suzuki, Fumiyuki
Hatakeyama, Hiromitsu
Mizumachi, Takatsugu
Furusawa, Jun
Taki, Shigenari
Furuta, Yasushi
Fukuda, Satoshi
AURIS NASUS LARYNX, 2009, 36 (01) : 57 - 63
[35] p53 codon 72 polymorphism association with head and neck squamous cell carcinoma
Mojtahedi, Zahra
Hashemi, Seyed Basir
Khademi, Bijan
Karimi, Morteza
Haghshenas, Mohammad Reza
Fattahi, Mohammad Javad
Ghaderi, Abbas
BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY, 2010, 76 (03) : 316 - 320
[36] P53 allelic loss and outcome in patients with squamous cell carcinoma of the head and neck
Rodrigo, JP
Coto, E
González, MV
Maldonado, M
Suárez, C
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2001, 258 (05) : 255 - 258
[37] Defective expression and function of p53 in head and neck squamous cell carcinoma cell lines
Friedman, Jay
Chen, Zhong
Van Waes, Carter
CANCER RESEARCH, 2006, 66 (08)
[38] Molecular and immunological aspects of p53 and p53-autoantibodies in head and neck squamous cell carcinoma
Cordes, C.
Von Lingen, J.
Goeroegh, T.
Ambrosch, P.
Gottschlich, S.
Hoffmann, M.
ONCOLOGY REPORTS, 2009, 22 (06) : 1299 - 1303
[39] NF-κB gene signatures and p53 mutations in head and neck squamous cell carcinoma -: Commentary
Ferris, Robert L.
Grandis, Jennifer R.
CLINICAL CANCER RESEARCH, 2007, 13 (19) : 5663 - 5664
[40] ALTERATION OF THE P53 GENE IN HUMAN HEAD AND NECK SQUAMOUS-CELL CARCINOMAS
WEISER, W
CASEY, G
PITCOCK, J
MEYSKENS, F
CLINICAL RESEARCH, 1992, 40 (01): : A63 - A63

← 1 2 3 4 5 →